Latest News

Given that the PROUD pilot study has answered the important question of how much protection daily Truvada can offer when provided in sexual health clinics in the UK, there is no need for the planned larger clinical trial. As such, we have withdrawn our funding application to reopen the PROUD study for new recruitment. In addition to daily Truvada, there is a range of other PrE ...

In April 2014, we announced that we had applied for additional funding to expand the PROUD pilot study into a full trial and if successful, hoped to reopen for recruitment early in 2015. A number of volunteers have already added their names to clinic registers of people interested in PrEP so they can be informed if recruitment reopens. In October 2014, an interim analysis of t ...

  An interim analysis of the PROUD study data has shown that pre-exposure prophylaxis (PrEP) is highly protective against HIV for gay men and other men who have sex with men (MSM) at high risk of infection. On this basis, the PROUD Trial Steering Committee has announced that participants currently on the deferred arm of the study, who have not yet started PrEP, will be offered ...

Thank you to all those who have enrolled, the study teams and the community organisations who have worked together to achieve this.Watch this space for updates – we have applied for additional funding to expand and if successful, hope to reopen study recruitment early in 2015. Meanwhile, some participating clinics are keeping a register of people interested in PrEP so they can ...

The PROUD pilot study now has 500 participants enrolled. ...